Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMNI | Common Stock Purchase Option | Award | $0 | +100K | +190.48% | $0.00 | 153K | Jun 4, 2021 | common stock | 100K | $0.50 | Direct | F1 |
transaction | AMNI | Convertible Promissory Note Payable | Other | $3.64K | 160K | Mar 31, 2021 | common stock | 7.27K | $0.50 | Direct | F2 | |||
transaction | AMNI | Warrant to purchase Common Stock | Other | $0 | +727K | +455.03% | $0.00 | 887K | Mar 31, 2021 | common stock | 727K | $0.50 | Direct | F2 |
Id | Content |
---|---|
F1 | On June 4, 2021 the Reporting Person was granted options to purchase 100,000 shares of common stock at an exercise price of $0.50 per share with a termination date of June 4, 2031. Such common stock purchase options vest on June 4, 2022 contingent upon the Reporting person's continued service to the Company at such point in time. |
F2 | On March 31, 2021 the reporting Person agreed to exchange accrued but unpaid compensation totaling $363,500 for a 3% convertible promissory note payable with a principal balance of $3,635 which is convertible into 7,270 shares of common stock and a maturity date of March 31, 2026. In addition, the Reporting Person was issued a detachable warrant to purchase a total of 727,000 shares of common stock at an exercise price of $0.50 per share |